BSE Live
Mar 04, 16:01Prev. Close
327.70
Open Price
319.30
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
NSE Live
Mar 04, 15:51Prev. Close
326.40
Open Price
332.00
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
320.40 (170)
| Key Financial Ratios of Panacea Biotec (in Rs. Cr.) | Mar 05 | |
| Per Share Ratios | ||
| Basic EPS (Rs.) | 4.77 | |
| Diluted EPS (Rs.) | 4.77 | |
| Cash EPS (Rs.) | 7.30 | |
| Book Value [ExclRevalReserve]/Share (Rs.) | 21.27 | |
| Book Value [InclRevalReserve]/Share (Rs.) | 21.27 | |
| Revenue from Operations/Share (Rs.) | 57.95 | |
| PBDIT/Share (Rs.) | 11.32 | |
| PBIT/Share (Rs.) | 8.88 | |
| PBT/Share (Rs.) | 7.13 | |
| Net Profit/Share (Rs.) | 4.77 | |
| NP After MI And SOA / Share (Rs.) | 4.77 | |
| Profitability Ratios | ||
| PBDIT Margin (%) | 19.53 | |
| PBIT Margin (%) | 15.31 | |
| PBT Margin (%) | 12.31 | |
| Net Profit Margin (%) | 8.23 | |
| NP After MI And SOA Margin (%) | 8.23 | |
| Return on Networth/Equity (%) | 22.44 | |
| Return on Capital Employed (%) | 18.26 | |
| Return on Assets (%) | 5.77 | |
| Total Debt/Equity (X) | 1.33 | |
| Asset Turnover Ratio (%) | 70.13 | |
| Liquidity Ratios | ||
| Current Ratio (X) | 1.69 | |
| Quick Ratio (X) | 0.70 | |
| Inventory Turnover Ratio (X) | 1.71 | |
| Dividend Payout Ratio (NP) (%) | 31.37 | |
| Dividend Payout Ratio (CP) (%) | 20.50 | |
| Earnings Retention Ratio (%) | 68.63 | |
| Cash Earnings Retention Ratio (%) | 79.50 | |
| Coverage Ratios | ||
| Interest Coverage Ratios (%) | 5.10 | |
| Interest Coverage Ratios (Post Tax) (%) | 5.10 | |
| Valuation Ratios | ||
| Enterprise Value (Cr.) | 925.34 | |
| EV/Net Operating Revenue (X) | 2.79 | |
| EV/EBITDA (X) | 14.30 | |
| MarketCap/Net Operating Revenue (X) | 2.06 | |
| Retention Ratios (%) | 68.62 | |
| Price/BV (X) | 5.62 | |
| Price/Net Operating Revenue | 2.06 | |
| Earnings Yield | 0.04 |
26.12.2025
16.12.2025
27.11.2025
26.11.2025
Panacea Biotec Consolidated September 2025 Net Sales at Rs 141.13 crore, down 4.22% Y-o-Y
26.11.2025
Panacea Biotec Consolidated September 2025 Net Sales at Rs 141.13 crore, down 4.22% Y-o-Y
24.11.2025
Panacea Biotec Standalone September 2025 Net Sales at Rs 90.81 crore, up 18.49% Y-o-Y
11.06.2025
Panacea Biotec Standalone March 2025 Net Sales at Rs 67.90 crore, down 15.52% Y-o-Y
03.06.2025
Panacea Biotec Consolidated March 2025 Net Sales at Rs 132.53 crore, down 2.88% Y-o-Y